BioCentury | Feb 23, 2018
Financial News

Addex proposes CHF40M private placement

...mGluR5; GRM5) has completed Phase IIb testing for PD-LID. Addex Therapeutics Ltd. (SIX:ADXN), Geneva, Switzerland Sandi Wong dipraglurant-ER Addex...
BioCentury | Feb 17, 2018
Financial News

Addex proposes CHF40M private placement

...which announced the offering after market close Thursday, was off CHF0.06 to CHF3.17 on Friday. Sandi Wong dipraglurant-ER Addex...
Items per page:
1 - 2 of 2